AMEFX
Price
$27.99
Change
+$0.01 (+0.04%)
Updated
Sep 11 closing price
Net Assets
149.58B
IPFCX
Price
$34.02
Change
+$0.09 (+0.27%)
Updated
Sep 11 closing price
Net Assets
37.27M
Interact to see
Advertisement

AMEFX vs IPFCX

AMEFX vs IPFCX Comparison Chart in %
View a ticker or compare two or three
VS
AMEFX vs. IPFCX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMEFX is a Hold and IPFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AMEFX has more cash in the bank: 150B vs. IPFCX (37.3M). AMEFX pays higher dividends than IPFCX: AMEFX (3.55) vs IPFCX (2.26). AMEFX was incepted earlier than IPFCX: AMEFX (18 years) vs IPFCX (12 years). IPFCX (1.45) is less costly to investors than AMEFX (0.37). AMEFX is a more actively managed with annual turnover of: 65.00 vs. IPFCX (29.00). AMEFX has a lower initial minimum investment than IPFCX: AMEFX (250) vs IPFCX (25000). IPFCX annual gain was more profitable for investors over the last year : 10.52 vs. AMEFX (5.18). AMEFX return over 5 years is better than : 26.11 vs. IPFCX (15.95).
AMEFXIPFCXAMEFX / IPFCX
Total Expense Ratio0.370.9041%
Annual Report Gross Expense Ratio0.371.4526%
Fund Existence18 years12 years-
Gain YTD8.81514.24262%
Front LoadN/AN/A-
Min. Initial Investment250250001%
Min. Initial Investment IRAN/AN/A-
Net Assets150B37.3M402,145%
Annual Yield % from dividends3.552.26157%
Returns for 1 year5.1810.5249%
Returns for 3 years39.4234.85113%
Returns for 5 years26.1115.95164%
Returns for 10 years62.2557.77108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDVZX21.510.15
+0.70%
Columbia Intrinsic Value Institutional
FFOTX54.76N/A
N/A
Fidelity Advisor Technology - Z
FRBRX213.20N/A
N/A
Franklin Biotechnology Discovery R6
BIREX16.30N/A
N/A
BlackRock Real Estate Securities Instl
EFEAX11.88N/A
N/A
Ashmore Emerging Mkts Frontier Eq A